ISSN 1662-4009 (online)

ey0019.4-4 | Important for clinical practice | ESPEYB19

4.4. Effects of growth hormone treatment on sleep-related parameters in adults with Prader-Willi syndrome

HH Shukur , L Hussain-Alkhateeb , Farholt S , O Norregaard , AP Jorgensen , C Hoybye

The Journal of Clinical Endocrinology & Metabolism, 2021, Vol. 106, No. 9, e3634–e3643PMID: 33950234Brief Summary: This trial explored the effects of rhGH treatment in patients with Prader-Willi syndrome (PWS) on respiratory and sleep parameters. The trial was randomized and placebo-controlled for 1 year, followed by a 2-year, open-phase GH treatment period. Polysomnography performed every 6 months revealed no adverse effects of rhGH tr...

ey0019.4-7 | Long-acting growth hormone (LAGH) | ESPEYB19

4.7. Effective gh replacement with once-weekly somapacitan vs daily GH in children with GHD: 3-year results from REAL 3

L Sa¨vendahl , T Battelino , MH Rasmussen , M Brod , P Saenger , R Horikawa

J Clin Endocrinol Metab, 2022. 107(5): p. 1357-1367. PMID: 34964458Brief Summary: This multicenter, randomized, controlled, phase 2 study compared the effects of once-weekly long-acting growth hormone (GH) somapacitan versus daily GH administered to GH-deficient (GHD) children over a period of 156 weeks. Efficacy estimates were height velocity (HV; cm/y) at year 3 and changes from baseline to end for height SDS, HV SDS, IGF-I SDS, and insulin-li...

ey0019.5-6 | Advances in clinical practice | ESPEYB19

5.6. Vitamin D level and fractures in children and adolescents: a systematic review and meta-analysis

C Zheng , H Li , S Rong , L Liu , K Zhen , K Li

Bone Miner Metab. 2021 Sep;39(5):851-857Abstract: https://pubmed-ncbi-nlm-nih-gov.proxy.kib.ki.se/34115219/In brief: Vitamin D plays a pivotal role in calcium homeostasis and bone health; a question is therefore frequently raised regarding the risk of fractures in children with vitamin D deficiency. This is more pertinent in safeguarding cases where it is not uncommon to fin...

ey0019.9-6 | Fertility issues and reproductive outcomes in childhood cancer survivors | ESPEYB19

9.6. Serum anti-mullerian hormone levels and risk of premature ovarian insufficiency in female childhood cancer survivors: systematic review and network meta-analysis

Torella M. , Riemma G. , De Franciscis P. , L Verde M. , Colacurci N.

gaetano.riemma@unicampania.it Cancers 2021, 13, 6331. PMID: 34944951.Brief Summary: This systematic review and meta-analysis examined the value of anti-Müllerian hormone (AMH) to predict premature ovarian failure (POI) in childhood cancer survivors (CCSs), compared to the general population.The potential toxic effect of alkylating agents and body irradiation on female...

ey0019.9-9 | Fertility issues and reproductive outcomes in childhood cancer survivors | ESPEYB19

9.9. Parenthood among men diagnosed with cancer in childhood and early adulthood: trends over time in a Danish national cohort

Sylvest R. , Vassard D. , Schmidt L. , Schmiegelow K. , Macklon K.T. , Forman J.L. , Pinborg A.

randi.lykke-sylvest@regionh.dk Human Reproduction, Vol.36, No.9, pp. 2576–2586, 2021. PMID: 34166497.Brief Summary: This Danish register-based cohort study investigated the rate of fatherhood among 9,353 men diagnosed with cancer during childhood or early adulthood (CSs), compared with 1,386,493 age-matched males without cancer. CSs became fathers slightly less frequently than controls (36...

ey0019.10-1 | Reviews | ESPEYB19

10.1. A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries

ZA Bhutta , RA Salam , A Gomber , L Lewis-Watts , T Narang , JC Mbanya , G Alleyne

Lancet. 2021 Nov 13;398(10313):1837-1850. https://pubmed.ncbi.nlm.nih.gov/34774146/Brief Summary: This review summarizes key aspects of type 1 diabetes (T1D), such as epidemiology, pathogenesis, risk factors and management. While reviewing and discussing these topics, the central theme of the review is the burden of T1D and the challenges encountered in its daily management in low- and midd...

ey0019.11-17 | Weight regulation and endocrine circuits (including interventions) | ESPEYB19

11.17. Critical review of bariatric surgical outcomes in patients with Prader-Willi syndrome and other hyperphagic disorders

MG Gantz , DJ Driscoll , JL Miller , JB Duis , MG Butler , L Gourash , J Forster , AO Scheimann

ascheim1@jhmi.edu Obesity (Silver Spring) 2022, 30(5):973–981 https://doi.org/10.1002/oby.23385Brief Summary: This review analyzes the outcomes after bariatric procedures among patients with Prader-Willi syndrome (PWS), melanocortin 4 receptor (MC4R) mutations, Bardet-Biedl syndrome (BBS), and hypothalamic obesity (HO). The benef...

ey0019.15-7 | New Hormones | ESPEYB19

15.7. A nutrient-specific gut hormone arbitrates between courtship and feeding

HH Lin , MC Kuang , I Hossain , Y Xuan , L Beebe , AK Shepherd , M Rolandi , JW Wang

Nature. 2022;602(7898):632-8. doi: 10.1038/s41586-022-04408-7.PubMed ID: 35140404Brief summary: This study in the fruit-fly, Drosophila melanogaster, identified a novel gut-derived, nutrient-specific neuropeptide hormone, ‘Diuretic hormone 31’ (Dh31), which triggers the insects to switch their behaviour from feeding to courtship and reproduction.Romantic di...

ey0017.2-4 | Neonatal Hypoglycaemia | ESPEYB17

2.4. Targeting glucose control in preterm infants: Pilot studies of continuous glucose monitoring

L Thomson , D Elleri , S Bond , J Howlett , DB Dunger , K Beardsall

To read the full abstract: Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F353–F359. PMID:30232094.In preterm and in the very low birthweight infants, hyperglycaemia is associated with increased risks of mortality, brain injury, retinopathy of prematurity and worse neurodevelopmental outcomes (1). Treatment of hyperglycaemia with continuous insulin infusion leads to increas...

ey0017.2-18 | Maternal Obesity and Long-Term Infant Consequences | ESPEYB17

2.18. Exposure to maternal obesity programs sex differences in pancreatic islets of the offspring in mice

LM Nicholas , M Nagao , LC Kusinski , DS Fernandez-Twinn , L Eliasson , SE Ozanne

To read the full abstract: Diabetologia. 2020 Feb;63(2):324–337. PMID:31773193Maternal obesity is a risk factor for the development of type 2 diabetes in the offspring. Exposure to maternal obesity alters pancreatic islet structure and function, including reduced beta-cell mass and impaired glucose stimulated insulin secretion, which both increase susceptibility to type 2 diab...